Abstract
Lifestyle changes such as exercise and dietary change are recommended first-line therapy for children with dyslipidemia, hypertension, and obesity. Although most clinicians recommend exercise, specific exercise prescriptions are not usually provided. The optimal type, duration, and intensity of activity to achieve a meaningful outcome is not definitively defined. As the pediatric population becomes more sedentary and morbidity accumulates from this lifestyle, understanding how targeted exercise prescriptions can benefit patients will be critical to effectively manage this group of patients. This review focuses on the role of exercise for the treatment of pediatric patients with dyslipidemia, hypertension, and obesity and describes additional factors that require future research to achieve desired outcomes in this at-risk population.
| Original language | English (US) |
|---|---|
| Pages (from-to) | e494-e498 |
| Journal | Pediatric annals |
| Volume | 47 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 1 2018 |
Fingerprint
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
Cite this
}
The role of exercise prescription in pediatric preventive cardiology programs. / Connolly, Sean D.; Ward, Kendra M.
In: Pediatric annals, Vol. 47, No. 12, 01.12.2018, p. e494-e498.Research output: Contribution to journal › Article
TY - JOUR
T1 - The role of exercise prescription in pediatric preventive cardiology programs
AU - Connolly, Sean D.
AU - Ward, Kendra M
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Lifestyle changes such as exercise and dietary change are recommended first-line therapy for children with dyslipidemia, hypertension, and obesity. Although most clinicians recommend exercise, specific exercise prescriptions are not usually provided. The optimal type, duration, and intensity of activity to achieve a meaningful outcome is not definitively defined. As the pediatric population becomes more sedentary and morbidity accumulates from this lifestyle, understanding how targeted exercise prescriptions can benefit patients will be critical to effectively manage this group of patients. This review focuses on the role of exercise for the treatment of pediatric patients with dyslipidemia, hypertension, and obesity and describes additional factors that require future research to achieve desired outcomes in this at-risk population.
AB - Lifestyle changes such as exercise and dietary change are recommended first-line therapy for children with dyslipidemia, hypertension, and obesity. Although most clinicians recommend exercise, specific exercise prescriptions are not usually provided. The optimal type, duration, and intensity of activity to achieve a meaningful outcome is not definitively defined. As the pediatric population becomes more sedentary and morbidity accumulates from this lifestyle, understanding how targeted exercise prescriptions can benefit patients will be critical to effectively manage this group of patients. This review focuses on the role of exercise for the treatment of pediatric patients with dyslipidemia, hypertension, and obesity and describes additional factors that require future research to achieve desired outcomes in this at-risk population.
UR - http://www.scopus.com/inward/record.url?scp=85058591666&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058591666&partnerID=8YFLogxK
U2 - 10.3928/19382359-20181114-01
DO - 10.3928/19382359-20181114-01
M3 - Article
C2 - 30543378
AN - SCOPUS:85058591666
VL - 47
SP - e494-e498
JO - Pediatric Annals
JF - Pediatric Annals
SN - 0090-4481
IS - 12
ER -